Vicarious Surgical (RBOTW) Long-Term Debt Issuances (2020 - 2021)

Vicarious Surgical (RBOTW) reported Long-Term Debt Issuances of $1.5 million for Q1 2021, up 261.45% quarter-over-quarter from $415000.0 in Q4 2020.

Vicarious Surgical (RBOTW) Long-Term Debt Issuances (2020 - 2021) Analysis & Trends

Vicarious Surgical (RBOTW) has 2 years of Long-Term Debt Issuances data on file, last reported at $1.5 million in Q1 2021.

Long-Term Debt Issuances for Q1 2021 came in at $1.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $1.5 million (changed N/A YoY), and the FY2022 annual result was $10.0 million, up 566.67% from the prior year.
Long-Term Debt Issuances advanced to $1.5 million in Q1 2021 per RBOTW's latest filing, from $415000.0 in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $1.5 million in Q1 2021 and troughed at $415000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	19.86 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	11.71 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	1.15 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Vicarious Surgical	-	-	-	-

Download Data